Navigation Links
Mylan Secures an Additional $300 Million of Committed Financing
Date:2/21/2012

PITTSBURGH, Feb. 21, 2012 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that it has entered into a facility agreement with a syndicate of banks to securitize up to $300 million of U.S. accounts receivable. The facility is committed and has a maturity of three years. The interest rate on any outstanding borrowings will be more than 100 basis points lower than the rate on the company's secured credit facilities.

Mylan Chief Financial Officer John Sheehan said: "We are pleased to have entered into this facility as it builds on our secured credit facility refinancing executed in November of last year and further serves to lower our weighted average borrowing costs. Today, Mylan has $1.55 billion of available committed financing through our secured credit and receivables financing facilities, providing the company with substantial operating flexibility."

Any amounts outstanding under the facility will be recorded as a secured loan and the receivables underlying any borrowings will continue to be included in the company's consolidated balance sheets.

About Mylan
Mylan Inc. ranks among the leading generic and specialty pharmaceutical companies in the world and provides products to customers in more than 150 countries and territories. The company maintains one of the industry's broadest and highest quality product portfolios supported by a robust product pipeline; operates one of the world's largest active pharmaceutical ingredient manufacturers; and runs a specialty business focused on respiratory, allergy and psychiatric therapies. For more information about Mylan, please visit www.mylan.com.


'/>"/>
SOURCE Mylan Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Mylan Announces Settlement Agreement Related to Antidepressant Effexor XR(R)
2. Mylan Receives FDA Approval for Generic Version of Parkinsons Treatment Sinemet(R)
3. Mylan Schedules Third Quarter 2009 Financial Results Conference Call and Live Webcast
4. Mylan Receives FDA Approval for Generic Version of Anticonvulsant Topamax(R) Sprinkle Capsules
5. Mylan Confirms First-to-File Patent Challenge Relating to Caduet(R)
6. Mylan Receives Approval for Generic Version of GoLytely(R)
7. Mylan Declares Quarterly Preferred Stock Dividend
8. Mylan Pre-Pays All Scheduled 2011 Term-Loan Borrowings
9. Mylan Confirms First-to-File Patent Challenge Relating to Vytorin(R) Cholesterol Medication
10. Mylans President of Europe, Middle East and Africa Elected President of European Generic Medicines Association
11. Mylan Receives Tentative FDA Approval Under PEPFAR for Matrix Laboratories New Drug Application (NDA) for Efavirenz Tablets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... , June 1, 2015 CEFALY Technology ... nerve stimulation device specifically authorized for use prior to ... from a new PET trial showing that the Cefaly ... the brain in migraine patients, namely the orbitofrontal cortex ... (PET) scan, which is an imaging test of the brain, used a ...
(Date:6/1/2015)... 2015 NSHOA Cancer Center and Heron ... positive, top-line results from its recently completed Phase ... safety of the Company,s 5-HT 3 receptor ... extended release) as part of a three-drug regimen ... receptor antagonist fosaprepitant and the IV corticosteroid dexamethasone ...
(Date:6/1/2015)... YORK , June 1, 2015   ... of Open, Transparent and Connected financial marketplaces for ... Incorporated, a San Diego -based ... traded on OTCQB®, America,s only public venture market ... Logo - http://photos.prnewswire.com/prnh/20110118/MM31963LOGO ...
Breaking Medicine Technology:New Study Shows CEFALY Returns Normal Metabolic Activity to Brain Areas in Migraine Patients 2New cancer therapy study results - MAGIC Trial 2OTC Markets Group Congratulates OncoSec Medical on NASDAQ Listing 2
... SAN DIEGO, Aug. 16, 2011 Optimer Pharmaceuticals, Inc. ... subgroup analysis of patients receiving concomitant systemic antibiotics in ... DIFICID™ (fidaxomicin) tablets in the treatment of adult patients ... online in the September 1 issue of Clinical ...
... 16, 2011 CVS/pharmacy announced today that all ... Compliance Corp.,s Environmental Return System, which provides customers ... unused, expired or unwanted drugs using affordable medication ... The postage-paid envelopes cost $3.99 and allow customers ...
Cached Medicine Technology:Clinical Infectious Diseases Publishes Subgroup Analysis Showing Optimer's DIFICID™ (fidaxomicin) Tablets Exhibited Higher Clinical Cure and Global Cure Rates Than Vancomycin in Patients with Clostridium difficile-Associated Diarrhea (CDAD) Receivin 2Clinical Infectious Diseases Publishes Subgroup Analysis Showing Optimer's DIFICID™ (fidaxomicin) Tablets Exhibited Higher Clinical Cure and Global Cure Rates Than Vancomycin in Patients with Clostridium difficile-Associated Diarrhea (CDAD) Receivin 3Clinical Infectious Diseases Publishes Subgroup Analysis Showing Optimer's DIFICID™ (fidaxomicin) Tablets Exhibited Higher Clinical Cure and Global Cure Rates Than Vancomycin in Patients with Clostridium difficile-Associated Diarrhea (CDAD) Receivin 4Clinical Infectious Diseases Publishes Subgroup Analysis Showing Optimer's DIFICID™ (fidaxomicin) Tablets Exhibited Higher Clinical Cure and Global Cure Rates Than Vancomycin in Patients with Clostridium difficile-Associated Diarrhea (CDAD) Receivin 5Clinical Infectious Diseases Publishes Subgroup Analysis Showing Optimer's DIFICID™ (fidaxomicin) Tablets Exhibited Higher Clinical Cure and Global Cure Rates Than Vancomycin in Patients with Clostridium difficile-Associated Diarrhea (CDAD) Receivin 6CVS/pharmacy Offers Customers Safe Disposal Program for Medications 2CVS/pharmacy Offers Customers Safe Disposal Program for Medications 3
(Date:6/1/2015)... Linda Kincaid, age 67, knew something was wrong. She ... she thought it was just a part of getting older, ... that. After going to the doctor, she received a distressing ... what might happen to her. , Linda is not alone. ... disease each year. Valve disease involves damage to one or ...
(Date:6/1/2015)... 2015 Cambia Health Solutions and ... new, interactive Affordable Care Act (ACA) training course ... called “Affordable Care Act Expert Series, Large Group ... and consultative insights necessary to effectively engage and ... impacts of the ACA. , The interactive, experience-based ...
(Date:6/1/2015)... New York, NY (PRWEB) June 01, 2015 ... largely by patients requesting celebrity features. Much like one ... their favorite stars’ noses, eyes, cheeks, chin and more ... other photo filtering apps like FaceTune are ushering in ... , Top Manhattan facial plastic surgeon, Sam Rizk, MD, ...
(Date:6/1/2015)... 01, 2015 Listen to Volvo’s Director ... companies are using more granular data to create better ... new industry voices in Josep Celaya Gonzalez, CIO at ... ParkTAG. As an automotive insurer, MAPFRE are well versed ... easy-to-use solution to the driver. Award winning start-up ParkTAG ...
(Date:6/1/2015)... 2015 A University of Texas ... signaling proteins that activate protein degradation, which helps ... 1 , The study published April 3rd ... Spraque-Dawley rats 2-3 months of age who performed ... given either whey protein (.4g/kg), low-dose Sustamine (.1g/kg), ...
Breaking Medicine News(10 mins):Health News:A New Online Resource for Those Living with Heart Valve Disease 2Health News:A New Online Resource for Those Living with Heart Valve Disease 3Health News:Cambia Partners with AHIP to Offer Expert Series ACA Training Course 2Health News:Cambia Partners with AHIP to Offer Expert Series ACA Training Course 3Health News:Instagram Filters Launch New Facial Plastic Surgery Trend 2Health News:Complimentary Webinar: Volvo, MAPFRE and Award Winning Start-Up discuss new Frontier of In-Car Services 2Health News:Study Shows Taking Sustamine® L-Alanyl-L-Glutamine May Reduce Muscle Protein Breakdown After Resistance Exercise 2Health News:Study Shows Taking Sustamine® L-Alanyl-L-Glutamine May Reduce Muscle Protein Breakdown After Resistance Exercise 3
... a tribal-dominated Orissa district in the past fortnight, say ... district. The victims contracted the disease after eating rotten buffalo ... and Sirimunda village, some 500 km from here, died of ... succumbed later, chief district medical officer K. Haribandhu Reddy told ...
... after a strong earthquake with a magnitude of 6.4 ... ,The quake shook the old downtown area of ... 5:34 a.m., with the epicentre at 23 degrees north and ... ,The quake also forced the evacuation of 120,000 residents, ...
... smoking in enclosed public spaces comes into force in the ... who might despair help is at hand. ,A ... the green light by the National Institute for Health and ... it should supply. ,The pill, taken twice a ...
... a retrospective study of 700 patients with culture-positive ... significantly higher in HIV-infected patients compared to ... relapse rates were higher in HIV-infected patients who ... to those receiving daily or longer treatment. ...
... University of Illinois Medical Center at Chicago performed a ... relieve him of debilitating pain. They also performed an ... surgical diabetes. ,Terry Near, of Rock Falls, ... undergo a pancreatectomy, or removal of the pancreas, using ...
... urging the developing world to look for new initiatives and ... services. But many nations in the African continent are hard ... ,Like elsewhere in the third world, visitors ... Lusaka hundreds of persons walking aimlessly along the roads, talking ...
Cached Medicine News:Health News:New Drug to Help Kick Smoking Habit Cleared in UK 2Health News:New Drug to Help Kick Smoking Habit Cleared in UK 3Health News:Treatment Outcomes of Patients With HIV and Tuberculosis 2Health News:First-Ever Robotic Pancreatectomy Performed at UIC 2Health News:Zambia Trying Hard to Tackle Crisis in Mental Health Care 2
... with 3 charging wells. Available In 4 ... and Cinnamon. Spring balanced refractor and slit ... construction for lifelong quality. Sealed hydraulic system ... movement. Chair back reclines manually to fully ...
... the patented HydroKeratome corneal cutting device for ... industry experts believe it will replace the ... used in the LASIK refractive procedure. In ... has demonstrated that its proprietary technology is ...
Our 2.5v Ophthalmoscope Sets feature high-quality instruments, handles, and cases....
3.5v Coaxial Ophthalmoscope Set with Convertible Handle and Hard Case. Our 3.5v Coaxial Ophthalmoscope Sets feature high-quality instruments, handles, and cases....
Medicine Products: